ArticleDiscover oncology2026

Molecular characterization and improved risk stratification of myelodysplastic syndromes with bone marrow fibrosis through integration of TP53 and MPL mutations.

Youshan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.